Healthcare stocks declined Friday afternoon, with the NYSE Healthcare Index shedding 0.8% and the State Street Health Care Select Sector SPDR ETF (XLV) decreasing 0.5%.

The iShares Biotechnology ETF (IBB) fell 2.2%.

In corporate news, AbbVie (ABBV) lowered its full-year earnings guidance on Friday to account for the expected dilution from its planned acquisition of Apogee Therapeutics (APGE), despite reporting stronger-than-expected Q2 results. AbbVie shares were down 2%.